New Journey(SZ:002219) Xin Lang Cai Jing·2026-01-12 02:56Company Overview - New Mile Health Technology Group Co., Ltd. is located at 28th Floor, Fortune Financial Center, No. 5 East Third Ring Middle Road, Chaoyang District, Beijing, established on September 30, 2001, and listed on March 6, 2008 [1] - The company's main business involves the manufacturing of pharmaceuticals (including traditional Chinese medicine pieces) and medical services, with revenue composition: 86.79% from medical services, 13.12% from pharmaceuticals and medical products, and 0.09% from others [1] Stock Performance - As of January 12, the stock price increased by 2.27%, reaching 2.25 CNY per share, with a trading volume of 97.99 million CNY and a turnover rate of 1.35%, resulting in a total market capitalization of 7.622 billion CNY [1] - Year-to-date, the stock price has risen by 5.63%, with a 3.21% increase over the last five trading days, a 1.81% increase over the last 20 days, and an 8.16% decline over the last 60 days [1] Financial Performance - For the period from January to September 2025, New Mile reported operating revenue of 2.256 billion CNY, a year-on-year decrease of 15.84%, and a net profit attributable to shareholders of -38.4682 million CNY, a year-on-year decrease of 172.86% [2] - Cumulative cash dividends since the A-share listing amount to 70.3476 million CNY, with no dividends paid in the last three years [3] Shareholder Information - As of December 31, the number of shareholders is 68,200, a decrease of 0.32% from the previous period, with an average of 48,004 circulating shares per person, an increase of 0.32% [2] - As of September 30, 2025, Hu Long Securities Co., Ltd. is the sixth largest circulating shareholder with 60 million shares, unchanged from the previous period, while Hong Kong Central Clearing Limited is the ninth largest new shareholder with 29.9322 million shares [3]